WSJ -- Johnson & Johnson (JNJ) said Tuesday that the U.S. Food and Drug Administration has rejected the company's application for a computer-assisted sedation system. J&J, which is appealing the FDA's decision on the "Sedasys" tool, also said it's once again pushing back its timeline for filing an FDA application for a new bleeding-control product.
